BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29914872)

  • 21. Inflammation suppression prevents tumor cell proliferation in a mouse model of thyroid cancer.
    Park S; Kim M; Zhu J; Lee WK; Altan-Bonnet G; Meltzer P; Cheng SY
    Am J Cancer Res; 2020; 10(6):1857-1870. PubMed ID: 32642296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin: current clinical applications in nondiabetic patients with cancer.
    Chen K; Li Y; Guo Z; Zeng Y; Zhang W; Wang H
    Aging (Albany NY); 2020 Feb; 12(4):3993-4009. PubMed ID: 32074084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Overweight and Obesity on US Papillary Thyroid Cancer Incidence Trends (1995-2015).
    Kitahara CM; Pfeiffer RM; Sosa JA; Shiels MS
    J Natl Cancer Inst; 2020 Aug; 112(8):810-817. PubMed ID: 31638139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model.
    Park S; Zhu J; Altan-Bonnet G; Cheng SY
    Am J Cancer Res; 2019; 9(7):1439-1453. PubMed ID: 31392080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of an anti-diabetic drug metformin in the treatment of endocrine tumors.
    Thakur S; Daley B; Klubo-Gwiezdzinska J
    J Mol Endocrinol; 2019 Aug; 63(2):R17-R35. PubMed ID: 31307011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase and Telomeres Biology in Thyroid Cancer.
    Donati B; Ciarrocchi A
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coding Molecular Determinants of Thyroid Cancer Development and Progression.
    Valvo V; Nucera C
    Endocrinol Metab Clin North Am; 2019 Mar; 48(1):37-59. PubMed ID: 30717910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into regulation of lipid metabolism by thyroid hormone.
    Zhu X; Cheng SY
    Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):408-13. PubMed ID: 20644471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extranuclear signaling of mutated thyroid hormone receptors in promoting metastatic spread in thyroid carcinogenesis.
    Lu C; Cheng SY
    Steroids; 2011 Aug; 76(9):885-91. PubMed ID: 21473875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer.
    Park S; Willingham MC; Qi J; Cheng SY
    Endocr Relat Cancer; 2018 Oct; 25(10):865-877. PubMed ID: 29914872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model.
    Park JW; Han CR; Zhao L; Willingham MC; Cheng SY
    Endocr Relat Cancer; 2016 Jan; 23(1):53-63. PubMed ID: 26552408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model.
    Kim WG; Park JW; Willingham MC; Cheng SY
    Endocrinology; 2013 Aug; 154(8):2936-47. PubMed ID: 23748362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
    Park J; Kim WG; Zhao L; Enomoto K; Willingham M; Cheng SY
    Oncotarget; 2016 Jun; 7(23):34832-44. PubMed ID: 27145454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.
    Park JW; Zhao L; Willingham MC; Cheng SY
    Am J Cancer Res; 2017; 7(3):727-739. PubMed ID: 28401024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.
    Zhu X; Kim DW; Zhao L; Willingham MC; Cheng SY
    Endocr Relat Cancer; 2016 Jul; 23(7):521-33. PubMed ID: 27267120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma.
    Iyer PC; Dadu R; Ferrarotto R; Busaidy NL; Habra MA; Zafereo M; Gross N; Hess KR; Gule-Monroe M; Williams MD; Cabanillas ME
    Thyroid; 2018 Jan; 28(1):79-87. PubMed ID: 29161986
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.